We are live on !
Find out more
Kings Path Partners Portfolio holdings
AUM
$380M
Turnover
14.5%
1-Year Est. Return
12.42%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+12.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$380M
AUM Growth
+$4.33M
(+1.2%)
Cap. Flow
+$9.6M
Cap. Flow % of AUM
Cap. Flow %
2.52%
Top 10 Holdings %
Top 10 Hldgs %
54.26%
Holding
393
New
40
Increased
71
Reduced
63
Closed
17
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Core Fixed Income ETF
DFCF
|
+$2.07M |
| 2 |
Vanguard Core Bond ETF
VCRB
|
+$1.94M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.89M |
| 4 |
NVIDIA
NVDA
|
+$1.89M |
| 5 |
Dimensional Global Core Plus Fixed Income ETF
DFGP
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis US Large Cap Value ETF
AVLV
|
+$876K |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$714K |
| 3 |
Targa Resources
TRGP
|
+$672K |
| 4 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$484K |
| 5 |
U.S. Targeted Value Portfolio ETF Class Shares
DFAT
|
+$445K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.18% |
| 2 | Technology | 2.09% |
| 3 | Healthcare | 1.96% |
| 4 | Energy | 1.76% |
| 5 | Financials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
DELISTED
BioLife Solutions
BLFS
| $644K | 0.17% |
16,570
| – | – |
2024 Q2
9 quarters
|
|
52
Willdan Group
WLDN
$1.1B
| $614K | 0.16% |
8,305
+2,395
| +41% | +$190K |
2026 Q1
2 quarters
|
|
53
Phibro Animal Health
PAHC
$1.58B
| $613K | 0.16% |
17,155
| – | – |
2025 Q1
6 quarters
|
|
54
Business First Bancshares
BFST
$1.03B
| $595K | 0.16% |
19,770
| – | – |
2024 Q2
9 quarters
|
|
55
iRadimed
IRMD
$1.08B
| $590K | 0.16% |
6,840
| – | – |
2024 Q2
9 quarters
|
|
56
Micron Technology
MU
$1.03T
| $565K | 0.15% |
530
+300
| +130% | +$285K |
2025 Q2
5 quarters
|
|
57
Metropolitan Bank Holding Corp
MCB
$1.21B
| $563K | 0.15% |
6,460
| – | – |
2024 Q2
9 quarters
|
|
58
Northern Trust Morningstar US Market Factor Tilt ETF
TILT
$2.2B
| $550K | 0.14% |
1,985
-45
| -2% | -$12.6K |
2024 Q2
9 quarters
|
|
59
Solaris Energy Infrastructure
SEI
$4.11B
| $513K | 0.13% |
7,205
-1,155
| -14% | -$70.4K |
2025 Q3
4 quarters
|
|
60
Liquidity Services
LQDT
$1.43B
| $500K | 0.13% |
11,675
+5,880
| +101% | +$241K |
2026 Q2
1 quarter
|
|
61
Berkshire Hathaway Class B
BRK.B
$1.17T
| $493K | 0.13% |
991
| – | – |
2024 Q2
9 quarters
|
|
62
UFP Technologies
UFPT
$2.27B
| $486K | 0.13% |
1,639
-571
| -26% | -$161K |
2024 Q2
9 quarters
|
|
63
Warby Parker
WRBY
$3.15B
| $476K | 0.13% |
17,125
+3,720
| +28% | +$96.7K |
2025 Q2
5 quarters
|
|
64
Excelerate Energy
EE
$1.02B
| $473K | 0.12% |
14,725
+3,730
| +34% | +$140K |
2024 Q3
8 quarters
|
|
65
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.5B
| $470K | 0.12% |
19,835
+1,567
| +9% | +$38.1K |
2024 Q2
9 quarters
|
|
66
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $469K | 0.12% |
6,523
-1
| -0% | -$75 |
2024 Q2
9 quarters
|
|
67
Chevron
CVX
$454B
| $459K | 0.12% |
2,249
-30
| -1% | -$5.91K |
2024 Q2
9 quarters
|
|
68
ANI Pharmaceuticals
ANIP
$1.66B
| $450K | 0.12% |
6,200
| – | – |
2024 Q2
9 quarters
|
|
69
NVE Corp
NVEC
$368M
| $448K | 0.12% |
4,070
-3,335
| -45% | -$353K |
2024 Q2
9 quarters
|
|
70
Green Brick Partners
GRBK
$2.77B
| $443K | 0.12% |
6,701
| – | – |
2024 Q2
9 quarters
|
|
71
Triumph Financial Inc
TFIN
$1.52B
| $435K | 0.11% |
7,255
| – | – |
2024 Q2
9 quarters
|
|
72
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$51.2B
| $432K | 0.11% |
4,718
| – | – |
2025 Q1
6 quarters
|
|
73
SPDR Gold Trust
GLD
$135B
| $422K | 0.11% |
1,109
| – | – |
2024 Q2
9 quarters
|
|
74
Guardian Pharmacy Services
GRDN
$2.47B
| $420K | 0.11% |
10,300
| – | – |
2025 Q4
3 quarters
|
|
75
Merck
MRK
$347B
| $408K | 0.11% |
2,809
+201
| +8% | +$27.8K |
2024 Q2
9 quarters
|
|
Similar funds
Kings Path Partners's Q3 2026 Portfolio in Review
As of Q3 2026, Kings Path Partners held 393 positions worth $380M, up 1.2% from $376M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Kings Path Partners's Q3 2026 filing shows 40 new, 71 increased, 63 reduced and 17 closed positions. Its largest new stake was Riskified: 47,620 shares worth $377K. The largest sale was Avantis US Large Cap Value ETF, an estimated $876K.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Healthcare.
- Kings Path Partners's largest Q3 2026 buy was Riskified: 47,620 shares worth $377K.
- Kings Path Partners added most to Dimensional Core Fixed Income ETF in Q3 2026, an estimated $2.07M increase.
- Kings Path Partners's biggest Q3 2026 reduction was Avantis US Large Cap Value ETF, cutting an estimated $876K.
- Kings Path Partners fully exited Douglas Dynamics in Q3 2026, selling an estimated $411K.
- Kings Path Partners's ten largest holdings make up 54% of its $380M portfolio in Q3 2026.
- Kings Path Partners opened 40 new positions and closed 17 in Q3 2026.
- Kings Path Partners's portfolio value rose 1.2% quarter-over-quarter to $380M.
Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.